The Importance of Hepatic Resection for Hepatocellular Carcinoma Originating From Nonfibrotic Liver
- 1 November 2000
- journal article
- Published by Wolters Kluwer Health in Journal of the American College of Surgeons
- Vol. 191 (5) , 531-537
- https://doi.org/10.1016/s1072-7515(00)00705-5
Abstract
Our study aimed to clarify the characteristics of hepatocellular carcinoma (HCC) in patients with a nonfibrotic liver and the role of surgical resection for HCC in nonfibrotic liver compared with patients with HCC in fibrotic or cirrhotic livers. A total of 516 patients who underwent hepatectomy between April 1985 and June 1999 were classified into two groups: a nonfibrotic liver group (n=65) and a fibrotic liver group (n=451), which included fibrotic or cirrhotic livers. Clinicopathologic variables were then compared between the groups, including disease-free survival rate and patient survival rate. Only 8 of 65 patients (12.3%) with a nonfibrotic liver showed a histologically completely normal liver. The numbers of men and patients with alcohol abuse in the nonfibrotic liver group were higher than in the fibrotic liver group. The numbers of patients with positive hepatitis B antigen and positive hepatitis C antibody in the nonfibrotic liver group were lower than in the fibrotic liver group. Results of liver function tests in the nonfibrotic liver group were better than those in the fibrotic liver group. The rates of both portal vein and hepatic vein invasion of cancer cells in the nonfibrotic liver group were higher than in the fibrotic liver group. The tumor size in the nonfibrotic liver group was larger than in the fibrotic liver group. The patient survival and disease-free survival rates in the nonfibrotic liver group were better than in the fibrotic liver group. Hepatic resection can be beneficial for patients with HCC originating from a nonfibrotic liver when compared with fibrotic or cirrhotic patients with HCC.Keywords
This publication has 23 references indexed in Scilit:
- Development of Hepatocellular Carcinoma in a Patient With Chronic Hepatitis C After 6 Years of a Sustained and Complete Response to IFN-αJournal of Clinical Gastroenterology, 1999
- Effect of Interferon Therapy on Hepatocellular Carcinogenesis in Patients With Chronic Hepatitis Type C: A Long–Term Observation Study of 1,643 Patients Using Statistical Bias Correction With Proportional Hazard AnalysisHepatology, 1999
- Assessment of Genetic Changes in Hepatocellular Carcinoma by Comparative Genomic Hybridization AnalysisThe American Journal of Pathology, 1999
- Prevalence of the haemochromatosis gene mutation in non-cirrhotic liver with hepatocellular carcinomaJournal of Hepatology, 1998
- HCV-associated hepatocellular carcinoma without cirrhosisJournal of Hepatology, 1996
- Classification of chronic hepatitis: Diagnosis, grading and stagingHepatology, 1994
- Current pathogenetic and molecular concepts in viral liver carcinogenesisVirchows Archiv B Cell Pathology Including Molecular Pathology, 1993
- Cirrhosis and the aetiology of hepatocellular carcinomaJournal of Hepatology, 1987
- 352. Note: Conservatism of the Approximation Σ(O - E) 2 /E in the Logrank Test for Survival Data or Tumor Incidence DataPublished by JSTOR ,1973
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958